Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 3, 2003, Pages 209-215

  Kirilovas, Dmitrijus ^a   Naessen, Tord ^a   Bergström, Mats ^a   Bonasera, Thomas A ^a   Bergström Pettermann, Elisabeth ^a   Holte, Jan ^a   Carlström, Kjell ^b   Simberg, Niklas ^a   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Androgens; Aromatase regulation; Granulosa cell; Non genomic mechanism; Vorozole

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CARBON 11; TESTOSTERONE; TRACER; TRITIUM OXIDE; VOROZOLE; ANDROSTANE-3,17-DIONE; ANDROSTANEDIONE; DRUG DERIVATIVE; ENZYME INHIBITOR; ETIOCHOLANOLONE; TRIAZOLE DERIVATIVE;

ARTICLE; ASSAY; BINDING ASSAY; CALCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INCUBATION TIME; LUTEAL CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; BINDING COMPETITION; ENZYMOLOGY; METABOLISM; NONPARAMETRIC TEST;

ANDROGENS; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITORS; BINDING, COMPETITIVE; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; ETIOCHOLANOLONE; FEMALE; GRANULOSA CELLS; HUMANS; STATISTICS, NONPARAMETRIC; TESTOSTERONE; TRIAZOLES;

EID: 0037363723     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00144.x     Document Type: Article

References (35)

1. Inkster SE, Brodie AM. Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab 1991; 73: 717-26.
2. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol 1994; 100: 51-4.
3. Suzuki T, Sasano H, Tamura M, Aoki H, Fukaya T, Yajima A et al. Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohistochemical study. Mol Cell Endocrinol 1993; 97: 135-43.
4. Robertson DM, Burger HG. Reproductive hormones: ageing and the perimenopause. Acta Obstet Gynecol Scand 2002; 81: 612-6.
5. McNatty KP. Hormonal correlates of follicular development in the human ovary. Aust J Biol Sci 1981; 34: 249-68.
6. Fitzpatrick SL, Richards JS. Regulation of cytochrome P450 aromatase messenger ribonucleic acid and activity by steroids and gonadotropins in rat granulosa cells. Endocrinology 1991; 129: 1452-62.
7. Zimniski SJ, Brandt ME, Covey DF, Puett D. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative. Steroids 1987; 50: 135-46.
8. Steinkampf MP, Mendelson CR, Simpson ER. Regulation by follicle-stimulating hormone of the synthesis of aromatase cytochrome P-450 in human granulosa cells. Mol Endocrinol 1987; 1: 465-71.
9. Chan WK, Tan CH. Induction of aromatase activity in porcine granulosa cells by FSH and cyclic AMP. Endocr Res 1987; 13: 285-99.
10. Whitelaw PF, Smyth CD, Howles CM, Hillier SG. Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary. J Mol Endocrinol 1992; 9: 309-12.
11. Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 1998; 4: 1-8.
12. Lephart ED, Simpson ER, McPhaul MJ. Ovarian aromatase cytochrome P-450 mRNA levels correlate with enzyme activity and serum estradiol levels in anestrous, pregnant and lactating rats. Mol Cell Endocrinol 1992; 85: 205-14.
13. Suzuki K, Tamaoki BI. Postovulatory decrease in estrogen production is caused by the diminished supply of aromatizable androgen to ovarian aromatase. Endocrinology 1980; 107: 2115-6.
14. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84: 2951-6.
15. Hillier SG. Intrafollicular paracrine function of ovarian androgen. J Steroid Biochem 1987; 27: 351-7.
16. Hillier SG, de Zwart FA. Androgen/antiandrogen modulation of cyclic AMP-induced steroidogenesis during granulosa cell differentiation in tissue culture. Mol Cell Endocrinol 1982; 28: 347-61.
17. Hillier SG, Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol 1997; 11: 249-60.
18. Wada Y, Tsuiki A, Fukaya T, Shinkawa O, Satoh S, Horiguchi M et al. Effects of androgen on 17 beta-estradiol production by cultured human granulosa cells. Tohoku J Exp Med 1988; 154: 253-60.
19. Harlow CR, Hillier SG, Hodges JK. Androgen modulation of follicle-stimulating hormone-induced granulosa cell steroidogenesis in the primate ovary. Endocrinology 1986; 119: 1403-5.
20. Hillier SG, van den Boogaard AM, Reichert LE Jr, van Hall EV. Alterations in granulosa cell aromatase activity accompanying preovulatory follicular development in the rat ovary with evidence that 5alpha-reduced C19 steroids inhibit the aromatase reaction in vitro. J Endocrinol 1980; 84: 409-19.
21. Meijs-Roelofs HM, Kramer P, van Cappellen WA, Gribling-Hegge L, Woutersen PJ. Periovulatory changes in serum concentration and ovarian content of 5 alpha-androstane-3 alpha, 17 beta-diol in the adult rat. Biol Reprod 1986; 35: 890-6.
22. Brandt ME, Puett D, Zimniski SJ. Divergence between ovarian aromatase activity, estrogen, and androgen levels in the cycling rat. Endocrinology 1990; 126: 72-9.
23. Dupon C, Kim MH. Peripheral plasma levels of testosterone, androstenedione, and oestradiol during the rat oestrous cycle. J Endocrinol 1973; 59: 653-4.
24. Kellis JT Jr, Vickery LE. The active site of aromatase cytochrome P-450. Differential effects of cyanide provide evidence for proximity of heme-iron and carbon-19 in the enzyme-substrate complex. J Biol Chem 1987; 262: 8840-4.
25. Kirilovas D, Bergstrom M, Bonasera TA, Bergstrom-Pettermann E, Naessen T, Holte Jet al. In vitro evaluation of aromatase enzyme in granulosa cells using a [11C]vorozole binding assay. Steroids 1999; 64: 266-72.
26. Newton CJ, Samuel DL, James VH. Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue. J Steroid Biochem 1986; 24: 1033-9.
27. Lidstrom P, Bonasera TA, Kirilovas D, Lindblom B, Lu L, Bergstrom E et al. Synthesis, in vivo rhesus monkey biodistribution and in vitro evaluation of a 11C-labelled potent aromatase inhibitor: [N-Methyl-11C]vorozole. Nucleic Med Biol 1998; 25: 497-501.
28. Johnston RF, Pickett SC, Barker DL. Autoradiography using storage phosphor technology. Electrophoresis 1990; 11: 355-60.
29. Koymans LM, Moereels H, Vanden Bossche H. A molecular model for the interaction between vorozole and other non-steroidal inhibitors and human cytochrome P450 19 (P450 aromatase). J Steroid Biochem Mol Biol 1995; 53: 191-7.
30. Chabab A, Sultan C, Fenart O, Descomps B. Stimulation of aromatase activity by dihydrotestosterone in human skin fibroblasts. J Steroid Biochem 1986; 25: 165-9.
31. Hillier SG, De Zwart FA. Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process invitro. Endocrinology 1981; 109: 1303-5.
32. Daniel SA, Armstrong DT. Involvement of estrogens in the regulation of granulosa cell aromatase activity. Can J Physiol Pharmacol 1983; 61: 507-11.
33. Zhuang LZ, Adashi EY, Hsuch AJ. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology 1982; 110: 2219-21.
34. Brailly S, Gougeon A, Milgrom E, Bomsel-Helmreich O, Papiernik E. Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J Clin Endocrinol Metab 1981; 53: 128-34.
35. Agarwal SK, Judd HL, Magoffin DA. A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81: 3686-91.